Mangeet Kaur Bouns: Page 20
Want to write for Entrepreneur too? Apply to join Entrepreneur Leadership network.
Latest: Page 20
Is This Biotech Stock a Rising Star in the Making?
Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is...
1 Railroad Stocks to Help Keep Your Portfolio Chugging Along
Leading transportation company CSX Corporation (CSX) reported impressive third-quarter results marked by solid earnings growth. Moreover, the company has immense potential for growth over the long run, driven by its...
1 Stock to Buy This Week Following Its Recent Earnings Beat
Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company's HIV and oncology franchises, which should...
1 Stock You Shouldn't Follow Cathie Wood Into This Fall
Shares of communication services company Twilio (TWLO) have plunged more than 80% in price year-to-date due to deteriorating financials and broader market weakness. Renowned investor Cathie Wood has recently gone...
1 Dividend Stock That's Worthy of Your Attention in Q4
Telecom giant Verizon (VZ) is undertaking various measures, including cost-saving and increasing focus on executing its 5G strategy, to boost its growth. The company's financial discipline and healthy balance sheet...
1 Stock Investors Will Be Glad They Bought This Fall
Leading Oil & Gas company Energy Transfer (ET) delivered impressive third-quarter results. Furthermore, the company raised its full-year 2022 guidance, considering strong energy demand. Given ET's solid dividend record and...
